The World Health Organisation (WHO) has issued a Medical Product Alert for two (2) confirmed falsified versions of amoxicillin + clavulanic acid products which are circulating in Haiti. These products are presented under the names “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav”.
According to a release sent by the Health Ministry, Genuine Amoxicillin/clavulanic acid is a combination, penicillin-type antibiotic, which is used to treat a wide variety of infections caused by bacteria, including infections of the ears, lungs, sinus, skin, and urinary tract.
Although Trinidad and Tobago was not included in the WHO alert, out of an abundance of caution, the Ministry of Health seeks to increase public awareness of this occurrence in Haiti.
The Ministry of Health is thereby advising the public, if you are in possession of the specific products (listed hereunder) please do not use. The falsified products are in the oral suspension form.
Augmentin and Amoxicillin Clavulanate Potassium
Batch Number 35405327A,
Exp 10 2020
Stated Manufacturer: Novopharm Limited and TEVA Pharmaceuticals USA
Batoclav
Batch Number BSTU0039
Manufacturing date 06/2017
Exp 05/2020
Stated Manufacturer: MYLAN
If you have taken these falsified medical products, or if you suffer an adverse event due to the consumption of these falsified products, please seek immediate advice from a qualified health care professional.
The Ministry of Health has also alerted other Government Border agencies to increase vigilance at the Borders.
It should be noted that the stated manufacturers of the products, MYLAN and Novopharm Limited and TEVA Pharmaceuticals USA, have informed the WHO that they have not produced these falsified products.
Members of the public may contact the Office of the Drug Inspectorate at 625-6049 and 627-0046 or the Chemistry Food and Drugs Division at 623-5242 for further information.
COMMENTS